文献速递心脏核医学肿瘤 PET/CT

人工智能衍生冠状动脉钙化在18F-flurpiridaz PET心肌灌注显像中的增量诊断价值

Incremental diagnostic value of artificial intelligence-derived coronary artery calcium in 18F-flurpiridaz positron emission tomography myocardial perfusion imaging.
PubMed 文献 · J Nucl Cardiol · 2025-10-14

本研究基于18F-flurpiridaz III期临床试验中498例接受PET/CT MPI并有CTAC扫描及6个月内ICA的患者,评估AI衍生CAC评分联合应激TPD对显著CAD的诊断增益。

要点

  • 联合CAC评分可提高18F-flurpiridaz PET MPI对显著CAD的诊断准确性。
  • AI衍生CAC评分与手动评分均带来增量价值,且无需额外扫描或技师时间。
  • 显著CAD定义为左主干≥50%狭窄或其他主要心外膜血管≥70%狭窄。

核心结论

  • 结合自动衍生的TPD与CAC评分可提高18F-flurpiridaz PET MPI检测显著CAD的准确性。

研究设计与样本

  • 研究纳入2011至2013年间18F-flurpiridaz III期临床试验中接受PET/CT MPI、有CTAC扫描用于CAC评分、并在6个月内行ICA的患者,共498例(72%男性,中位年龄63岁)。
  • TPD自动定量,CAC评分分别采用AI衍生分割和手动评分,比较应激TPD单独与联合CAC评分的AUC。

主要发现

  • 498例患者中30.1%患有CAD。

关键数值与推荐

  • 显著CAD定义为左主干≥50%狭窄或其他主要心外膜血管≥70%狭窄。

临床怎么用

  • 在18F-flurpiridaz PET/CT MPI中,可利用CTAC扫描自动获取CAC评分,与TPD联合提升CAD诊断准确性,无需额外扫描或技师时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Positron emission tomography (PET) myocardial perfusion imaging (MPI) is a powerful tool for predicting coronary artery disease (CAD). Coronary artery calcium (CAC) provides incremental risk stratification to PET-MPI and enhances diagnostic accuracy. We assessed the additive value of the CAC score, derived from PET/CT attenuation maps to stress total perfusion deficit (TPD) results using the novel 18F-flurpiridaz tracer in detecting significant CAD. METHODS: Patients from the 18F-flurpiridaz phase III clinical trial who underwent PET/CT MPI with the 18F-flurpiridaz tracer, had available computed tomography attenuation correction (CTAC) scans for CAC scoring, and underwent invasive coronary angiography (ICA) within a 6-month period between 2011 and 2013 were included. TPD was quantified automatically, and CAC scores from CTAC scans were assessed using artificial intelligence (AI)-derived segmentation and manual scoring. Obstructive CAD was defined as ≥50% stenosis in the left main (LM) artery, or 70% or more stenosis in any of the other major epicardial vessels. Prediction performance for CAD was assessed by comparing the area under receiver operating characteristic curve (AUC) for stress TPD alone and in combination with the CAC score. RESULTS: Among 498 patients (72% males, median age 63 years) 30.1% had CAD. Incorporating the CAC score resulted in a greater AUC with manual scoring (AUC = .87, 95% confidence interval [CI]: .34-.90; P = .015) and AI-based scoring (AUC = .88, 95% CI: .85-.90; P = .002) compared to stress TPD alone (AUC = .84, 95% CI: .80-.92). CONCLUSIONS: Combining automatically derived TPD and CAC score enhances 18F-flurpiridaz PET MPI accuracy in detecting significant CAD, offering a method that can be routinely used with PET/CT scanners without additional scanning or technologist time.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Barrett O, Shanbhag A, Zaid R, et al. Incremental diagnostic value of artificial intelligence-derived coronary artery calcium in 18F-flurpiridaz positron emission tomography myocardial perfusion imaging. J Nucl Cardiol. 2025. PMID: 41101453. doi:10.1016/j.nuclcard.2025.102532

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。